ResMed Financial Diagnostics

RMD -- USA Stock  

USD 105.03  4.10  4.06%

ResMed diagnostics interface makes it easy to digest most current publicly released information about ResMed as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis ResMed price relationship with some important fundamental indicators such as market cap and management efficiency.

ResMed Note

About 67.0% of the company shares are owned by institutional investors. The company last dividend was issued on 2018-08-15. ResMed had 2:1 split on 2010-08-31. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and is traded on New York Stock Exchange. It employs 5940 people. To find out more about RESMED INC contact Michael Farrell at 858-836-5000 or learn more at

ResMed Alerts

ResMed generates negative expected return over the last 30 days
About 67.0% of the company shares are owned by institutional investors
Latest headline from Exercise or conversion by David Pendarvis of 2810 shares of ResMed subject to Rule 16b-3

ResMed Upcoming Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017

ResMed Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare

Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 16.44 B.


The company has Net Profit Margin of 13.49 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 29.07 % which entails that for every 100 dollars of revenue it generated 0.29 of operating income.

Management Efficiency

ResMed has Return on Asset of 10.72 % which means that on every $100 spent on asset it made $10.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.7 % implying that it generated $15.7 on every 100 dollars invested.

Stock Holders for ResMed

At Risk
SPDR SPSPDR SP Health Care Equipment ETF(0.09) (2.31) 
VPMSXVantagepoint MidSmall Company Index II 0.00  0.00 
VALICVALIC Company I Mid Cap Index(0.30) (2.03) 
UMPSXProFunds UltraMid Cap Svc(0.36) (4.10) 
UMPIXProFunds UltraMid Cap Inv(0.35) (4.08) 
MotleyMotley Fool Small Mid Cap Growth Inv(0.29) (3.63) 
SPDR SPSPDR SP 400 US Mid Cap ETF 0.00  0.00 
SheltonShelton SP Midcap Index Direct(0.24) (2.13) 
iSharesiShares Russell 2500 ETF 0.00  0.00 
ObesityThe Obesity ETF(0.20) (2.91) 
Schwab USSchwab US Mid Cap ETF(0.21) (1.98) 
Rydex MidRydex Mid Cap 1 5x Strategy H(0.07) (2.70) 
GuggenheGuggenheim SP 500 Eq Weight HC ETF(0.0094) (2.40) 
NuSharesNuShares ESG Mid Cap Growth ETF(0.30) (2.09) 
VanEckVanEck Vectors SPASX MidCap ETF(0.07) (2.39) 
ProFundsProFunds Mid Cap Svc(0.25) (2.04) 
RealityReality Shares Divcon Leaders Div ETF(0.17) (2.54) 
JPMorganJPMorgan Divers Ret US Mid Cp Eq ETF(0.19) (1.64) 
JPMorganJPMorgan US Minimum Volatility(0.0281) (1.26) 
FidelityFidelity Growth Strategies(0.18) (3.11) 

Technical Drivers

ResMed holds Coefficient Of Variation of 263.40 and Risk Adjusted Performance of 0.41. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of ResMed as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for ResMed which can be compared to its competitors. Please check ResMed Information Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed is priced some-what accurately providing market reflects its current price of 105.03 per share. Given that ResMed has Jensen Alpha of 0.60, we recommend you check out ResMed recent market performance to make sure the company can sustain itself at future point.

ResMed Price Movement Analysis

Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

ResMed Insider Trading Activities

ResMed Technical and Predictive Indicators

ResMed Forecast Models


ResMed Analyst Recommendations

Target PriceAdvice# of Analysts
ResMed current and past analyst recommendations published by number of research institutions as well as average analyst consensus
ResMed Analyst Advice  

Vital Value Indicators

ResMed Basic Pricing Drivers

Quick Ratio1.32
Fifty Two Week Low75.62
Trailing Annual Dividend Rate1.42
Revenue Growth12.00%
Payout Ratio63.93%
Shares Short Prior Month3.19M
Average Daily Volume Last 10 Day701.55k
Average Daily Volume In Three Month686.98k
Earnings Growth7.50%
Shares Percent Shares Out2.10%
Gross Margins58.21%
Earnings Quarterly Growth8.10%
Short Percent Of Float2.13%
Forward Price Earnings27.96
Float Shares140.81M
Fifty Two Week High116.64
Enterprise Value To Ebitda24.37
Fifty Day Average111.29
Two Hundred Day Average104.71
Trailing Annual Dividend Yield1.23%
Enterprise Value To Revenue7.09
Additionally take a look at Your Equity Center. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.